Streetbeat News

Analyst Ratings

ECVT

BWS Financial analyst Hamed Khorsand maintains a Buy rating on Ecovyst (NYSE:ECVT) but lowers the price target from $18 to $12.

Portfolio Pulse from Benzinga Newsdesk

August 05, 2024 | 4:15 pm

WCC

Stephens & Co. analyst Tommy Moll has reiterated an Overweight rating on WESCO International (NYSE:WCC) and maintained a price target of $190.

Portfolio Pulse from Benzinga Newsdesk

August 05, 2024 | 4:13 pm

DKNG

Macquarie analyst Chad Beynon maintains an Outperform rating on DraftKings (NASDAQ:DKNG) but lowers the price target from $52 to $50.

Portfolio Pulse from Benzinga Newsdesk

August 05, 2024 | 4:12 pm

LSEA

Oppenheimer analyst Tyler Batory maintains an Outperform rating on Landsea Homes (NASDAQ:LSEA) and raises the price target from $14 to $15.

Portfolio Pulse from Benzinga Newsdesk

August 05, 2024 | 4:11 pm

CBOE

Oppenheimer analyst Owen Lau maintains an Outperform rating on Cboe Global Markets (BATS:CBOE) and raises the price target from $199 to $209.

Portfolio Pulse from Benzinga Newsdesk

August 05, 2024 | 4:10 pm

IEX

Oppenheimer analyst Bryan Blair maintains an Outperform rating on IDEX (NYSE:IEX) but lowers the price target from $245 to $238.

Portfolio Pulse from Benzinga Newsdesk

August 05, 2024 | 4:08 pm

CLGN

EF Hutton has initiated coverage on CollPlant Biotechnologies (NASDAQ:CLGN) with a Buy rating and set a price target of $14.

Portfolio Pulse from Benzinga Newsdesk

August 05, 2024 | 4:07 pm

DKNG

Oppenheimer analyst Jed Kelly maintains an Outperform rating on DraftKings (NASDAQ:DKNG) but lowers the price target from $58 to $55.

Portfolio Pulse from Benzinga Newsdesk

August 05, 2024 | 4:06 pm

VRTX

Oppenheimer analyst Hartaj Singh maintains an Outperform rating on Vertex Pharmaceuticals (NASDAQ:VRTX) and raises the price target from $500 to $550.

Portfolio Pulse from Benzinga Newsdesk

August 05, 2024 | 4:04 pm

FBMS

RNST

Renasant Corp (NYSE:RNST) shares dropped after announcing a public offering and a deal with The First Bancshares Inc (NYSE:FBMS). Piper Sandler upgraded RNST from Neutral to Overweight, raising the price target from $35 to $40, citing improved scale and profitability.

Portfolio Pulse from Priya Nigam

August 05, 2024 | 4:03 pm